Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Juárez León (Ciudad de México, Mexico), M. Alberti (Buenos Aires, Argentina), V. Wolff (Santiago de Chile, Chile), F. Reyes (Santiago de Chile, Chile), F. Paulin (Buenos Aires, Argentina), L. Fassola (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), G. Carballo (Buenos Aires, Argentina), T. Palavecino (Santiago de Chile, Chile), J. Díaz (Santiago de Chile, Chile), I. Buendía Roldán (Ciudad de México, Mexico), M. Mejía (Ciudad de México, Mexico), M. Florenzano (Santiago de Chile, Chile), J. Rojas Serrano (Ciudad de México, Mexico). Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort.. 1371

Member's Comments

No comment yet.

Related content which might interest you: Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened Source: Eur Respir J 2016; 47: 1293-1295 Year: 2016 Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened Source: Eur Respir J 2016; 47: 1295-1296 Year: 2016 Clinical features of patients with desquamative interstitial pneumonia: Association with autoimmune disorders Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 Variables associated with functional improvement in patients with interstitial lung disease and myositis related antibodies: Results from a multicentric Latin American study. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Lung manifestations of chronic granulomatous disease; a clinical survey of patients from the Iranian primary immunodeficiency registry Source: Eur Respir J 2001; 18: Suppl. 33, 510s Year: 2001 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort. Source: International Congress 2017 – Novel and old entities Year: 2017 Interstitial pneumonia with autoimmune features (IPAF): a clinical entity? Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020 Year: 2021 Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia Source: International Congress 2017 – Lung function testing Year: 2017 Characterisation of patients with interstitial pneumonia with autoimmune features Source: Eur Respir J 2016; 47:1767-1775 Year: 2016